Clinical Trial Update: Once-A-Day Pregabalin For Partial Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial update for once-daily pregabalin in partial seizures has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsies Partial
• Partial Seizures

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Partial Seizures, Epilepsies, Partial | Phase 3 | Status: COMPLETED | Results posted: 2018-06-06